Combined Primary Tumor and Extracranial Metastasis Status as Constituent Factor of Prognostic Indices for Predicting the Overall Survival in Patients with Brain Metastases

被引:2
|
作者
Park, Young Hee [1 ,2 ]
Kim, Tae Hyun [1 ]
Jung, Sun-Young [3 ]
Kim, Young-Eun [3 ]
Bae, Jong-Myon [3 ]
Kim, Yeon-Joo [1 ]
Choi, Ji Hoon [1 ]
Lee, Nam Kwon [1 ]
Moon, Sung Ho [1 ]
Kim, Sang Soo [1 ]
Shin, Kyung Hwan [1 ]
Kim, Joo-Young [1 ]
Kim, Dae Yong [1 ]
Cho, Kwan Ho [1 ]
机构
[1] Natl Canc Ctr, Res Inst & Hosp, Goyang 410769, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea
[3] Natl Evidence Based Healthcare Collaborating Agcy, Seoul, South Korea
关键词
Brain Metastasis; Prognostic Index; Radiotherapy; STEREOTACTIC RADIOSURGERY; RADIATION-THERAPY; RANDOMIZED-TRIAL; BREAST-CANCER; LUNG-CANCER; RADIOTHERAPY; WOMEN; MODEL;
D O I
10.3346/jkms.2013.28.2.205
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We retrospectively analyzed the prognostic factors on overall survival (OS) in patients with brain metastasis (BM) and evaluated the role of combined primary tumor and extracranial metastasis (ECM) status as a constituent factor for prognostic index. This study involved 897 patients with BMs who underwent radiotherapy between April 2003 and December 2009. Among the clinical parameters, multivariate analysis showed that age, Karnofsky performance status (KPS), combined primary tumor and ECM status, number of BMs, and treatment group were significant prognostic factors for OS (P < 0.05). To compare the discriminatory ability of 5 prognostic indices, i.e., recursive partitioning analysis (RPA), basic score for BMs (BSBM), score index for radiosurgery (SIR), graded prognostic assessment (GPA), and modified GPA including the combined primary tumor and ECM status (mGPA), the Akaike information criteria (AIC) were calculated. The mGPA showed the lowest AIC value, followed by RPA, GPA, SIR, and BSBM, in that order. It is implicated that modified score of pre-existing factors (i.e., age and KPS) and addition of the combined primary tumor and ECM status to the prognostic index can improve its discriminatory ability and the combined primary tumor and ECM status may be useful as one of constituent factors for prognostic index.
引用
收藏
页码:205 / 212
页数:8
相关论文
共 50 条
  • [41] Is Ambulatory Status a Prognostic Factor of Survival in Patients with Spinal Metastases? An Exploratory Meta-analysis
    Yang, Xiong-gang
    Han, Yue
    Wang, Feng
    Liu, Yong-heng
    Hu, Yong-cheng
    Lun, Deng-xing
    Feng, Jiang-tao
    Hua, Kun-chi
    Yang, Li
    Zhang, Hao
    Xu, Ming-you
    Zhang, Hao-ran
    ORTHOPAEDIC SURGERY, 2018, 10 (03) : 173 - 180
  • [42] Very Early PSA Response to Abiraterone in mCRPC Patients: A Novel Prognostic Factor Predicting Overall Survival
    Facchini, Gaetano
    Caffo, Orazio
    Ortega, Cinzia
    D'Aniello, Carmine
    Di Napoli, Marilena
    Cecere, Sabrina C.
    Della Pepa, Chiara
    Crispo, Anna
    Mines, Francesca
    Ruatta, Fiorella
    Iovane, Gelsomina
    Pisconti, Salvatore
    Montella, Maurizio
    Berretta, Massimiliano
    Pignata, Sandro
    Cavaliere, Carla
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [43] Incidence of brain metastases and overall survival in patients with primary cardiac sarcoma: A retrospective case series.
    Shango, Maryann
    Zhao, Lili
    Leja, Monika
    McHugh, Jonathan B.
    Schuetze, Scott
    Chugh, Rashmi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] EFFECT OF TUMOR SUBTYPE ON SURVIVAL AND THE GRADED PROGNOSTIC ASSESSMENT FOR PATIENTS WITH BREAST CANCER AND BRAIN METASTASES
    Sperduto, Paul W.
    Kased, Norbert
    Roberge, David
    Xu, Zhiyuan
    Shanley, Ryan
    Luo, Xianghua
    Sneed, Penny K.
    Chao, Samuel T.
    Weil, Robert J.
    Suh, John
    Bhatt, Amit
    Jensen, Ashley W.
    Brown, Paul D.
    Shih, Helen A.
    Kirkpatrick, John
    Gaspar, Laurie E.
    Fiveash, John B.
    Chiang, Veronica
    Knisely, Jonathan P. S.
    Sperduto, Christina Maria
    Lin, Nancy
    Mehta, Minesh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (05): : 2111 - 2117
  • [45] Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases
    Berghoff, Anna S.
    Fuchs, Elisabeth
    Ricken, Gerda
    Mlecnik, Bernhard
    Bindea, Gabriela
    Spanberger, Thomas
    Hackl, Monika
    Widhalm, Georg
    Dieckmann, Karin
    Prayer, Daniela
    Bilocq, Amelie
    Heinzl, Harald
    Zielinski, Christoph
    Bartsch, Rupert
    Birner, Peter
    Galon, Jerome
    Preusser, Matthias
    ONCOIMMUNOLOGY, 2016, 5 (01):
  • [46] HER-2 Status as a Prognostic Factor in Patients with Brain Metastases from Breast Cancer
    Oh, K. S.
    Syed, Z.
    Raad, R. Abi
    Taghian, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S222 - S222
  • [47] A New Prognostic Tool for Predicting the Overall Survival of ALK Positive Non-small Cell Lung Cancer with Brain Metastasis
    Liang, X.
    Wang, H.
    Zhai, S.
    Li, Y.
    Que, S.
    Feng, W.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S355 - S355
  • [48] Brain metastases: Extracranial disease status as a prognostic factor after whole brain radiotherapy. Results from a prospective, population-based study
    Yri, O. E.
    Astrup, G. L.
    Hjermstad, M. J.
    Aass, N. K.
    Lund, J-A.
    Van Helvoirt, R.
    Paulsen, O.
    Kaasa, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S526 - S526
  • [49] Overall survival and progression free survival in patients with primary brain tumors after treatment. Is 18F FDOPA PET/CT a prognostic factor in these patients?
    Chiaravalloti, A.
    Fiorentini, A.
    Villani, V.
    Carapella, C.
    D'Elia, A.
    Sannino, P.
    Zinzi, M.
    Urbano, N.
    Grillea, G.
    Palombo, E.
    Schillaci, O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S195 - S195
  • [50] Overall survival and progression-free survival in patients with primary brain tumors after treatment: is the outcome of [18F] FDOPA PET a prognostic factor in these patients?
    Agostino Chiaravalloti
    Vincenzo Esposito
    Francesco Ursini
    Eugenio Di Giorgio
    Maddalena Zinzi
    Ferdinando Calabria
    Andrea Cimini
    Orazio Schillaci
    Annals of Nuclear Medicine, 2019, 33 : 471 - 480